| Active substance | upadacitinib |
| Holder | Abbvie |
| Status | closed |
| Indication | treatment of adults with severe Ankylosing Spondylitis who have no other suitable treatment option and are not eligible to participate in a clinical study. |
| Public documents | Approbation |
| Informed consent | |
| Last update | 10/08/2022 |